Feline lymphoma is one of the most commonly diagnosed cancers in cats, yet its varied clinical presentations and complex diagnostic pathway can make recognition and management challenging in first-opinion practice. From cats presenting with vague gastrointestinal signs to those with respiratory, neurological or nodal disease, lymphoma should remain an important differential diagnosis for many unwell feline patients.
Join this CPD webinar – part of the BVA and In Practice webinar series – to explore the clinical presentations of feline lymphoma, understand how to approach staging and diagnostic testing, and gain practical insights into discussing treatment options and prognosis with clients. The session will provide a structured approach to diagnosis and case management, helping you feel more confident when guiding owners through what can be a challenging diagnosis.
What you'll learn
Join this session and leave with:
-
a clear understanding of the clinical presentations of feline lymphoma
-
the ability to develop an appropriate staging plan
-
an understanding of which diagnostic tests to perform and when
-
an overview of the diagnostic tools available
-
an understanding of the treatment options available, including the role of chemotherapy and radiotherapy
-
practical guidance on discussing diagnosis, treatment choices, prognosis and quality-of-life considerations with clients.
Why attend?
If you're looking to strengthen your approach to diagnosing and managing feline lymphoma, this session will provide practical, evidence-based guidance that you can apply immediately in practice.
Whether you're investigating a suspected case, planning diagnostic tests or supporting owners through treatment decisions, you'll leave with greater confidence in managing this common and clinically diverse disease.
Part of the BVA and In Practice webinar series
Enhance your learning by reviewing 'Feline lymphoma: diagnosis, staging and clinical presentation' ahead of the session, an In Practice article by Sarah and Charlie.
Meet the speakers
Charlie Pittaway
Charlie graduated from the University of Bristol in 2014. After a year in small animal practice, he undertook a rotating Internship at the University of Cambridge, followed by a residency programme in medical oncology. He finished this in 2019 after which he joined DWR. In April 2021, he became a Diplomate of the European College of Veterinary Internal Medicine (Oncology), and in 2023 DWR Head of Oncology. Charlie has a particular interest in the diagnosis and treatment of round cell tumours. He has previously lectured at BSAVA congress and is an Associate Professor at the University of Nottingham, where he is also a guest lecturer.
Sarah Mason
Sarah is double boarded in oncology and radiation oncology and gained 15 years of experience working in multidisciplinary referral centres before establishing OncoTails a remote peripatetic oncology service which provides specialist support to vets to keep Oncology cases in practice. Sarah is a Fellow of the Royal College of Veterinary Surgeons and has published extensively in the field of canine and feline clinical oncology.
